Harvard Bioscience Announces Upcoming Earnings Call
In an exciting development for investors and stakeholders, Harvard Bioscience, Inc. (Nasdaq: HBIO) is set to disclose its financial performance for the quarter ended June 30, 2025. This announcement will occur before the market opens on August 11, 2025, followed by a conference call at 8:00 a.m. Eastern Time, where the company will delve into the specifics of its financial results.
Participating in the Conference Call
Individuals interested in participating in this significant conference call are encouraged to register ahead of time. Upon registration, participants will receive important dial-in numbers and a unique PIN that will facilitate their involvement. This is a wonderful opportunity for stakeholders to gain insights directly from company leaders concerning the quarter’s achievements and challenges.
Audio-Only Webcast
For those preferring to listen to the call without participating directly, an audio-only webcast will be made available. This can be accessed via Harvard Bioscience’s investor website, which will host the live audio feed. It’s a convenient way to stay informed about the company's latest developments.
Key Financial Information and Resources
During the conference call, alongside the earnings release, a slide presentation will be available to enhance understanding of the financial results. This comprehensive information will also be accessible on Harvard Bioscience’s Investor Relations section on their website, allowing for a thorough review of the figures and related data.
About Harvard Bioscience
Harvard Bioscience is renowned for advancing life sciences through their innovative technologies, products, and services. Their work enables significant progress in various applications including research and biotechnology. The company’s broad customer base ranges from prestigious academic institutions and government laboratories to major pharmaceutical and biotech organizations. Harvard Bioscience operates on a global scale, with a presence in the United States, Europe, and China, showcasing their commitment to enhancing scientific endeavors worldwide.
Contact Information for Investors
For further inquiries about the upcoming earnings call or other investor-related questions, you can reach out to their investor relations team directly at (508) 893-3120. Alternatively, investors can also contact them via email at investors@harvardbioscience.com.
Frequently Asked Questions
What is the date and time of the earnings conference call?
The earnings conference call is scheduled for August 11, 2025, at 8:00 a.m. Eastern Time.
How can I join the conference call?
Participants must register to obtain the dial-in numbers and a unique PIN for joining the call.
Will there be a webcast available for the earnings call?
Yes, an audio-only webcast will be available on the investor website for those who prefer to listen in.
Where can I find the financial results after the call?
The financial results, including the earnings release and slide presentation, will be published on the Investor Relations section of their website.
How can I contact investor relations for more questions?
You can contact investor relations at (508) 893-3120 or via email at investors@harvardbioscience.com.
